HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS

To provide humanized rodents for testing therapeutic agents.SOLUTION: Provided herein are methods and compositions relating to the in vivo testing of therapeutic agents comprising a human Fc in genetically modified rodents (e.g., the testing of pharmacokinetic and/or pharmacodynamic properties of su...

Full description

Saved in:
Bibliographic Details
Main Authors MCWHIRTER JOHN, COREY MOMONT, KEBBEDE ANTENEH, VERA VORONINA, LYNN MACDONALD, NAXIN TU
Format Patent
LanguageEnglish
Japanese
Published 22.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide humanized rodents for testing therapeutic agents.SOLUTION: Provided herein are methods and compositions relating to the in vivo testing of therapeutic agents comprising a human Fc in genetically modified rodents (e.g., the testing of pharmacokinetic and/or pharmacodynamic properties of such a therapeutic agent in genetically modified rodents). In some embodiments, the genetically modified rodents express antibodies comprising a human Fc (e.g., a human IgG1 Fc, a human IgG4 Fc). In some embodiments, the rodents express fully human antibodies (i.e., antibodies having human heavy chains and human light (γ or κ) chains).SELECTED DRAWING: Figure 1A 【課題】治療薬を試験するためのヒト化げっ歯類の提供。【解決手段】本明細書で提供されるのは、遺伝子改変されたげっ歯類における、ヒトFcを含む治療薬のin vivo試験(例えば、遺伝子改変されたげっ歯類における、かかる治療薬の薬物動態及び/または薬力学的特性の試験)に関する方法及び組成物である。いくつかの実施形態では、遺伝子改変されたげっ歯類は、ヒトFc(例えば、ヒトIgG1 Fc、ヒトIgG4 Fc)を含む抗体を発現する。いくつかの実施形態では、げっ歯類は、完全ヒト抗体(すなわち、ヒト重鎖及びヒト軽鎖(γまたはκ)を有する抗体)を発現する。【選択図】図1A
Bibliography:Application Number: JP20230083923